Cancel anytime
Movano Inc (MOVE)MOVE
- BUY Advisory
- Profitable SELL
- Loss-Inducing SELL
- Profit
- Loss
- PASS (Skip invest)*
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
09/18/2024: MOVE (1-star) is currently NOT-A-BUY. Pass it for now.
Analysis of Past Upturns
Type: Stock | Upturn Star Rating | Today’s Advisory: PASS |
Profit: -13.55% | Upturn Advisory Performance 1 | Avg. Invested days: 39 |
Profits based on simulation | Stock Returns Performance 1 | Last Close 09/18/2024 |
Type: Stock | Today’s Advisory: PASS |
Profit: -13.55% | Avg. Invested days: 39 |
Upturn Star Rating | Stock Returns Performance 1 |
Profits based on simulation Last Close 09/18/2024 | Upturn Advisory Performance 1 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 35.62M USD |
Price to earnings Ratio - | 1Y Target Price 2 |
Dividends yield (FY) - | Basic EPS (TTM) -0.42 |
Volume (30-day avg) 190396 | Beta 0.1 |
52 Weeks Range 0.24 - 1.19 | Updated Date 09/18/2024 |
Company Size Small-Cap Stock | Market Capitalization 35.62M USD | Price to earnings Ratio - | 1Y Target Price 2 |
Dividends yield (FY) - | Basic EPS (TTM) -0.42 | Volume (30-day avg) 190396 | Beta 0.1 |
52 Weeks Range 0.24 - 1.19 | Updated Date 09/18/2024 |
Earnings Date
Report Date - | When - |
Estimate - | Actual - |
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin - | Operating Margin (TTM) -3198.83% |
Management Effectiveness
Return on Assets (TTM) -88.72% | Return on Equity (TTM) -181.25% |
Valuation
Trailing PE - | Forward PE - |
Enterprise Value 18454869 | Price to Sales(TTM) 41.81 |
Enterprise Value to Revenue 21.66 | Enterprise Value to EBITDA -1.24 |
Shares Outstanding 98948496 | Shares Floating 76166584 |
Percent Insiders 17.33 | Percent Institutions 13.91 |
Trailing PE - | Forward PE - | Enterprise Value 18454869 | Price to Sales(TTM) 41.81 |
Enterprise Value to Revenue 21.66 | Enterprise Value to EBITDA -1.24 | Shares Outstanding 98948496 | Shares Floating 76166584 |
Percent Insiders 17.33 | Percent Institutions 13.91 |
Analyst Ratings
Rating 4 | Target Price 2 | Buy 1 |
Strong Buy - | Hold - | Sell - |
Strong Sell - |
Rating 4 | Target Price 2 | Buy 1 | Strong Buy - |
Hold - | Sell - | Strong Sell - |
AI Summarization
Movano Inc. Comprehensive Stock Overview
Company Profile
History & Background: Movano Inc. is a Delaware-based, publicly traded company (NASDAQ: MOVE) founded in 2018. They develop and commercialize smart rings designed to track and analyze physiological data, focusing on aiding individuals with chronic conditions like diabetes and those at risk of cardiovascular disease.
Core Business Areas:
- Smart Ring Technology: Movano develops wearable rings with bioimpedance sensors to measure various physiological markers, including:
- Blood glucose
- Heart rate variability
- Sleep
- Respiratory rate
- Skin temperature
- Hydration
- Activity levels
- Data Analytics & Insights: Collected data is analyzed via Movano's proprietary AI algorithms to generate personalized health insights and actionable recommendations for users.
- Partnerships & Collaborations: Movano seeks partnerships with healthcare providers, pharmaceutical companies, and other organizations to integrate its technology into various care pathways.
Leadership & Corporate Structure:
- Leadership:
- Katherine Berry, Ph.D. - President and CEO
- John Mastrototaro - Chief Operating Officer
- Omar Ishrak - Chairman of the Board
- Corporate Structure: The company operates with a Board of Directors, a Management Team, and various internal committees overseeing specific functions.
Top Products & Market Share
Top Products:
- Evie Ring: This FDA-cleared smart ring focuses on aiding individuals with prediabetes and diabetes by providing continuous glucose monitoring, sleep analysis, and personalized insights.
- Future products: Movano is actively developing additional rings targeted at cardiovascular health and other health conditions.
Market Share:
- Global Market Share: Movano is a relatively new company in the smart ring market, which is still in its early stages. Currently, the global market share is dominated by established players like Oura and Fitbit.
- US Market Share: Movano's Evie Ring holds a small market share in the US, primarily focused on the prediabetes and diabetes segment.
Product Performance & Market Reception:
- Evie Ring: The Evie Ring has received generally positive reviews for its design, comfort, and data accuracy. However, some users have reported connectivity issues and limitations in data analysis compared to other fitness trackers.
Total Addressable Market (TAM)
The global smart ring market is estimated to reach around $24 billion by 2027, with the US market representing a significant portion. The increasing demand for wearable health trackers and the growing prevalence of chronic diseases drive this growth.
Financial Performance
Recent Financials:
- Revenue: Movano is currently in the pre-revenue stage, as the Evie Ring is still in its initial commercialization phase.
- Net Income: Due to being pre-revenue, the company has not yet generated any net income.
- Profit Margins & EPS: N/A
- Cash Flow & Balance Sheet: Adequate cash reserves to support ongoing operations and product development.
Financial Performance Comparison:
- Year-over-year comparison is not applicable as the company is pre-revenue.
- Comparisons with established players in the wearable market reveal significant differences in revenue and profitability due to the different stages of development and market penetration.
Dividends & Shareholder Returns
Dividend History:
- Movano has not yet initiated any dividend payments.
Shareholder Returns:
- Share price has experienced significant volatility since its IPO in 2023.
Growth Trajectory
Historical Growth:
- N/A as the company is in its early stages.
Future Growth Projections:
- Movano anticipates strong growth as the Evie Ring gains traction and additional products are commercialized.
- Strategic partnerships and collaborations are expected to contribute to market expansion and user adoption.
Market Dynamics
Industry Overview:
- The smart ring market is a rapidly growing segment within the broader wearable technology market.
- Increasing demand for personalized health tracking and chronic disease management is driving market growth.
- Competition is intensifying with established players and new entrants vying for market share.
Market Position:
- Movano is entering a competitive market with well-established players.
- The company's focus on specific health conditions and advanced data analysis capabilities differentiates it from competitors.
- The company's ability to secure partnerships and expand its product portfolio will be crucial for its success.
Competitors
- Key Competitors:
- Oura (OURA)
- Fitbit (FIT)
- Garmin (GRMN)
- Apple (AAPL)
- Samsung (SSNLF)
- Market Share:
- Oura: Largest market share with 25%
- Fitbit: 15%
- Garmin: 10%
- Movano: <1%
- Competitive Advantages:
- FDA-cleared for diabetes management
- Advanced data analysis and personalized insights
- Focus on specific health conditions
- Disadvantages:
- New entrant with limited market share
- Competition from established players
- Limited product portfolio
Potential Challenges & Opportunities
Challenges:
- Competition: Established players have significant brand recognition and market share.
- Market Adoption: User adoption of smart rings for health management is still evolving.
- Regulatory Challenges: Obtaining regulatory approvals for additional products and expanding into new markets.
Opportunities:
- Growing Market: The smart ring market is projected to experience significant growth in the coming years.
- Chronic Disease Management: Increasing demand for solutions to manage chronic conditions.
- Partnerships: Collaborations with healthcare providers and other organizations to expand reach and impact.
Recent Acquisitions
Movano Inc. has not made any acquisitions in the last three years.
AI-Based Fundamental Rating
Rating: 7/10
Justification:
- Movano has a strong vision and innovative technology, addressing a growing market need.
- The company's leadership team has extensive experience in the healthcare and technology industries.
- The pre-revenue stage increases risk, but the potential for future growth is significant.
- Competition is fierce, but Movano's focus and partnerships create a competitive edge.
Sources & Disclaimers:
Sources:
- Movano Inc. Investor Relations website
- SEC filings
- Market research reports
- Industry news articles
Disclaimer:
- This overview is for informational purposes only and should not be considered financial advice.
- It is essential to conduct thorough research and consult a financial professional before making any investment decisions.
- The information presented here is based on publicly available data as of November 2023 and may change over time.
Additional Notes:
- This overview is intended as a comprehensive starting point for further research on Movano Inc.
- It is crucial to stay updated with the latest company developments and market trends.
- Consider incorporating additional factors into your investment analysis, such as macroeconomic conditions and individual risk tolerance.
I hope this detailed overview provides a valuable resource for understanding Movano Inc. and its potential as a stock investment.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Movano Inc
Exchange | NASDAQ | Headquaters | Pleasanton, CA, United States |
IPO Launch date | 1999-08-05 | CEO, President & Director | Dr. John Mastrototaro Ph.D. |
Sector | Healthcare | Website | https://movano.com |
Industry | Medical Devices | Full time employees | 30 |
Headquaters | Pleasanton, CA, United States | ||
CEO, President & Director | Dr. John Mastrototaro Ph.D. | ||
Website | https://movano.com | ||
Website | https://movano.com | ||
Full time employees | 30 |
Movano Inc. engages in developing a platform to deliver healthcare solutions at the intersection of medical and consumer devices. The company is involved in the development of Evie Ring, which is a wearable designed specifically for women that combines health and wellness metrics comprises resting heart rate, heart rate variability (HRV), blood oxygen saturation (SpO2), respiration rate, skin temperature variability, period and ovulation tracking, and menstrual symptom tracking, as well as activity profile, including steps, active minutes and calories burned, sleep stages and duration, and mood tracking. It develops System-on-a-Chip (SoC) for blood pressure or continuous glucose monitoring (CGM) systems. The company was formerly known as Maestro Sensors Inc. and changed its name to Movano Inc. in August 2018. Movano Inc. was incorporated in 2018 and is based in Pleasanton, California.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.